Imunon, Inc. (IMNN)
1.28
-0.04
(-3.03%)
USD |
NASDAQ |
Oct 02, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Imunon Max Drawdown (5Y) : 99.49% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.49% |
| August 31, 2026 | 99.49% |
| July 31, 2026 | 99.49% |
| June 30, 2026 | 99.49% |
| May 31, 2026 | 99.49% |
| April 30, 2026 | 99.49% |
| March 31, 2026 | 99.49% |
| February 28, 2026 | 99.49% |
| January 31, 2026 | 99.49% |
| December 31, 2025 | 99.49% |
| November 30, 2025 | 99.49% |
| October 31, 2025 | 99.49% |
| September 30, 2025 | 99.49% |
| August 31, 2025 | 99.49% |
| July 31, 2025 | 99.49% |
| June 30, 2025 | 99.49% |
| May 31, 2025 | 99.49% |
| April 30, 2025 | 99.38% |
| March 31, 2025 | 99.38% |
| February 28, 2025 | 99.38% |
| January 31, 2025 | 99.38% |
| December 31, 2024 | 99.38% |
| November 30, 2024 | 99.38% |
| October 31, 2024 | 99.38% |
| September 30, 2024 | 99.38% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.38% |
| July 31, 2024 | 99.38% |
| June 30, 2024 | 99.38% |
| May 31, 2024 | 99.38% |
| April 30, 2024 | 99.38% |
| March 31, 2024 | 99.38% |
| February 29, 2024 | 99.38% |
| January 31, 2024 | 99.35% |
| December 31, 2023 | 99.17% |
| November 30, 2023 | 98.88% |
| October 31, 2023 | 98.82% |
| September 30, 2023 | 98.80% |
| August 31, 2023 | 98.63% |
| July 31, 2023 | 98.63% |
| June 30, 2023 | 98.63% |
| May 31, 2023 | 98.63% |
| April 30, 2023 | 98.63% |
| March 31, 2023 | 98.51% |
| February 28, 2023 | 98.51% |
| January 31, 2023 | 98.51% |
| December 31, 2022 | 99.54% |
| November 30, 2022 | 99.59% |
| October 31, 2022 | 99.69% |
| September 30, 2022 | 99.74% |
| August 31, 2022 | 99.78% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agenus, Inc. | 98.84% |
| Amgen, Inc. | 24.86% |
| BioCryst Pharmaceuticals, Inc. | 79.10% |
| Curis, Inc. | 99.98% |
| CEL-SCI Corp. | 99.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -86.71 |
| Beta (5Y) | 2.012 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 89.58% |
| Historical Sharpe Ratio (5Y) | -0.7432 |
| Historical Sortino (5Y) | -1.667 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.21% |